Replies to post #184232 on Amarin Corp Plc (AMRN)

[relocatedmetsfan]

Quote: 7 billon on cancer

It’s a $1.35 billion up front payment, the rest is are payments based on “sales and regulatory milestones”. Sounds like a pretty significant CVR...

For development of a single cancer drug to treat breast and gastric cancer...which pales in comparison to the CVD market.

This has a very positive impact on Amarin valuations, no?

Does this take AZN out of the running as a potential buyer?